The U.S. Food and Drug Administration (U.S. FDA) has issued an establishment inspection report (EIR) with a voluntary action indicated (VAI) classification to the Granules Pharmaceuticals Inc. (GPI)...
A ₹1,200 crore manufacturing facility of generic drugmaker Aurobindo Pharma’s subsidiary TheraNyM Biologics near Hyderabad, with a potential to generate more than 1,500 jobs for the local youth, was...